If you’ve been paying attention to the anti-aging treatments hub lately, you’ve probably noticed polynucleotides — sold under acronyms like PDRN and PN — moving from clinic menus into mainstream skincare. Browse any dermatology forum or K-beauty discussion board and someone is asking about “salmon DNA skincare.” It sounds sci-fi, and honestly, the origin story is a little wild. But there’s enough peer-reviewed research behind this ingredient class to make it worth a serious look. This guide, part of our broader beauty articles library, breaks down what polynucleotides are, what the evidence currently supports, and where the marketing may outpace the science. Results may vary.
What Are Polynucleotides and PDRN?
Polynucleotides (PN) are long-chain DNA fragments derived primarily from salmon or trout sperm cells. PDRN (Polydeoxyribonucleotide) is a specific, purified fraction of these fragments used in both medical and cosmetic contexts for its potential tissue-regenerating properties.
At their core, polynucleotides are chains of nucleotides — the building blocks of DNA. When sourced from salmon, they share a high structural compatibility with human DNA, which researchers believe may support cellular repair mechanisms in the skin. PDRN is the pharmaceutical-grade, highly purified version, originally developed for wound healing and tissue regeneration in clinical settings. The cosmetic industry has since adopted both PN and PDRN into serums, creams, and injectable treatments, most famously the Rejuran line of skin boosters. It’s worth noting that the concentration, delivery method, and purity of these ingredients can vary enormously between a clinic injectable and an over-the-counter topical product.
How Do Polynucleotides Work for Skin Regeneration?
Polynucleotides are thought to support skin regeneration by activating adenosine receptors, which may stimulate fibroblast activity, collagen synthesis, and reduce inflammatory markers — though much of the strongest evidence comes from injectable and clinical formulations.
The Adenosine Receptor Pathway
One of the most cited mechanisms is PDRN’s interaction with adenosine A2A receptors on skin cells. Peer-reviewed studies on PDRN and wound healing via PubMed suggest this interaction may promote fibroblast proliferation — meaning the cells responsible for producing collagen and elastin may become more active. This is why PDRN earned serious clinical attention long before it became a skincare trend. The caveat: most robust studies have focused on wound healing, diabetic ulcers, and post-procedure recovery rather than cosmetic aging specifically.
Collagen Stimulation and Skin Thickness
Some clinical studies on injectable polynucleotide treatments have reported improvements in skin hydration, elasticity, and thickness after a course of sessions. Evidence-based explainers on polynucleotide skincare ingredients note that results from topical formulations are less well-documented, partly because large polynucleotide molecules face significant barriers when attempting to penetrate the skin’s outer layer. This is an important distinction that’s often glossed over in product marketing.
Anti-Inflammatory Properties
PDRN may also help modulate inflammatory responses in the skin. For people dealing with redness, sensitized skin, or post-procedure irritation, this anti-inflammatory potential is part of why polynucleotides have attracted interest beyond purely cosmetic anti-aging applications. Research is preliminary in this specific context, and broader clinical trials are still needed.
Rejuran Treatment and PDRN Skin Rejuvenation: What Does the Evidence Show?
Rejuran is a South Korean injectable polynucleotide treatment that has become one of the most studied PN formulations for cosmetic use. Clinical trial results show some promise for skin quality improvements, though study sizes areа often small and longer-term data is limited.
Earlier foundational research helped establish the biological rationale behind PDRN-based skin rejuvenation, particularly its potential role in fibroblast stimulation and collagen synthesis. More recent reviews published in 2024 and 2025 on polynucleotides in aesthetic medicine have expanded on these findings, reporting promising improvements in skin elasticity, hydration, texture, and wrinkle appearance — especially in injectable formulations. At the same time, researchers continue to emphasize that evidence quality remains uneven, with many studies involving relatively small sample sizes and limited long-term follow-up. This is why most dermatologists currently view polynucleotides as a promising adjunct in regenerative skincare rather than a replacement for gold-standard anti-aging ingredients like retinoids.
The Rejuran treatment involves micro-injections of highly concentrated PN directly into the dermis, bypassing the absorption challenge that topical products face. Patients typically undergo a series of sessions spaced a few weeks apart. Some users report improvements in skin texture, pore appearance, and overall skin quality, though results vary considerably and are not guaranteed. The American Academy of Dermatology guidelines on skin regeneration treatments recommend consulting a board-certified dermatologist before pursuing any injectable treatment, as individual suitability, technique, and aftercare all influence outcomes.
Salmon DNA Skincare Benefits: Separating Fact from Marketing
The “salmon DNA” label in skincare can refer to anything from pharmaceutical-grade PDRN to much lower concentrations of polynucleotide fragments. Understanding the difference helps consumers evaluate whether a product is likely to deliver meaningful results.
What Topical Products Can and Can’t Do
Topical serums and creams containing polynucleotides face a genuine scientific challenge: skin is designed to keep things out. Larger molecules, like intact polynucleotide chains, struggle to penetrate deeply enough to reach fibroblasts. Brands are addressing this with techniques like hydrolysis (breaking PN into smaller fragments) or encapsulation technology, but peer-reviewed evidence specifically validating these delivery methods in cosmetic PN products is still limited. That doesn’t mean topical products are useless — surface-level hydration and barrier support may still occur — but the mechanisms likely differ from injectable treatments.
Ingredient Concentration and Quality
Not all polynucleotide ingredients are equal. PDRN specifically refers to a fraction of DNA extracted and purified to pharmaceutical standards. Products labeled with “polynucleotides” or “PN” may contain varying grades and concentrations. When evaluating a product, looking for transparency around the concentration and source of the ingredient is a reasonable starting point, though this information isn’t always disclosed on consumer packaging.
Polynucleotide Skincare vs. Other Regenerative Ingredients: A Comparison
| Ingredient | Primary Mechanism | Evidence Strength | Typical Delivery | Key Limitation |
|---|---|---|---|---|
| PDRN / Polynucleotides | Adenosine receptor activation, fibroblast stimulation | Moderate (clinical); Limited (topical) | Injectable, serum, cream | Molecular size limits topical penetration |
| Retinol (Vitamin A) | Accelerates cell turnover, boosts collagen | Strong (decades of peer-reviewed data) | Topical | Can cause irritation; sun sensitivity |
| Hyaluronic Acid | Humectant, surface hydration | Strong for hydration; Limited for deep structural change | Topical, injectable filler | Temporary effect; doesn’t regenerate tissue |
| Peptides (e.g., Matrixyl) | Signal proteins to stimulate collagen | Moderate; some well-designed clinical studies | Topical | Effectiveness varies widely by peptide type |
| Growth Factors | Cellular communication, repair signaling | Promising but early-stage for cosmetics | Topical, injectable | Stability in formulations is challenging |
According to researchers at the University of Genoa reviewing PDRN applications in tissue repair, PDRN demonstrated consistent pro-angiogenic and anti-inflammatory effects across multiple study models, supporting its continued investigation for both wound care and cosmetic dermatology applications.
Alternative Perspectives
Not everyone in the dermatology community is equally enthusiastic about the polynucleotide skincare trend. Some clinicians argue that the evidence base — while real — is still too narrow and predominantly drawn from wound-healing contexts rather than cosmetic aging. Skeptics point out that consumer-grade topical products may leverage the clinical reputation of PDRN injectables without offering comparable benefits. Others raise questions about long-term effects and the regulatory inconsistency in how PN ingredients are classified and labeled across markets. Proponents counter that even modest anti-inflammatory and hydration benefits are meaningful for sensitive or aging skin, and that injectable formulations have a legitimate evidence trail. The consensus view, broadly, is that polynucleotides are a promising but still-evolving ingredient class — not a replacement for established actives like retinoids, but potentially a useful complement.
Is Polynucleotide Skincare Right for Your Anti-Aging Routine?
Polynucleotides may suit people seeking gentle, regenerative support — particularly those with sensitive skin who find retinoids too irritating. They may work best as part of a layered skincare routine rather than as a standalone solution.
If you’re considering topical PN products, looking for formulations that combine polynucleotides with complementary ingredients — like peptides, niacinamide, or ceramides — may make sense, as these have their own supporting evidence. For injectable Rejuran or PDRN treatments, consulting a qualified, board-certified dermatologist is essential. Individual factors like skin type, age, existing conditions, and treatment history all shape whether and how well these treatments perform. Results may vary.
Frequently Asked Questions
PDRN (Polydeoxyribonucleotide) is a specific, pharmaceutical-grade purified fraction of polynucleotide chains, originally developed for medical wound healing. “Polynucleotides” (PN) is a broader term covering various DNA fragment chains used in skincare. PDRN represents the most clinically studied and standardized form; not all PN products on the market contain the same purity or concentration.
This is one of the key unresolved questions. Polynucleotide molecules are relatively large, which limits how deeply they penetrate the skin’s barrier in standard topical formulations. Some brands use hydrolysis or encapsulation to break fragments into smaller sizes, but peer-reviewed evidence validating these specific delivery approaches in cosmetic products remains limited. Injectable forms bypass this challenge entirely.
Clinical protocols vary, but many practitioners recommend an initial course of 3 to 4 sessions spaced approximately 2 to 4 weeks apart, followed by maintenance sessions every few months. Individual recommendations depend on skin condition, age, and treatment goals. A board-certified dermatologist should assess your specific situation before you begin any injectable treatment plan.
Polynucleotides are generally considered to have a favorable tolerability profile, and some research suggests anti-inflammatory properties that may suit sensitive skin. That said, individual reactions vary, and product formulations include other ingredients that may cause sensitivity. Patch testing new products and introducing them gradually is always advisable, particularly for reactive skin types. Consult a dermatologist if you have specific concerns.